Search Results - andrew+zimmerman

1 Results

Sort By:

Hydroxyurea in Autism

C11387: Hydroxyurea for the Treatment of AutismNovelty: This technology employs hydroxyurea (HU), a common treatment for sickle cell disease, to reduce core symptoms, like social responsiveness, in patients of all ages with autism.Value Proposition: Currently, the only available drugs for the treatment of autism are symptomatic. These drugs aim to...

Published: 3/13/2025 | Inventor(s): Kirby Smith, Andrew Zimmerman

Keywords(s): Antagonists/Inhibitors, Autism, CNS and Neurological Disorders, Disease Indication, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Psychiatry > Autism, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Psychiatry, Technology Classifications > Therapeutic Modalities